OptimizeRx Corporation

NasdaqCM:OPRX Stock Report

Market Cap: US$194.6m

OptimizeRx Balance Sheet Health

Financial Health criteria checks 5/6

OptimizeRx has a total shareholder equity of $126.6M and total debt of $36.2M, which brings its debt-to-equity ratio to 28.6%. Its total assets and total liabilities are $183.4M and $56.8M respectively.

Key information

28.6%

Debt to equity ratio

US$36.23m

Debt

Interest coverage ration/a
CashUS$13.85m
EquityUS$126.55m
Total liabilitiesUS$56.82m
Total assetsUS$183.37m

Recent financial health updates

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Recent updates

OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Jan 09
OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

Aug 24
Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Aug 16
OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

May 31
Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx: A Top Candidate For My Speculative 'Bio Boom' Portfolio

Oct 12

Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

Sep 23
Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx extends reach with Cooler Screens Partnership

Jul 26

OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability

Jun 27

The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Nov 16
The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

Aug 13
Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Jul 15
A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

May 10
Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

Estimating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Mar 29
Estimating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Don't Ignore The Fact That This Insider Just Sold Some Shares In OptimizeRx Corporation (NASDAQ:OPRX)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In OptimizeRx Corporation (NASDAQ:OPRX)

What Percentage Of OptimizeRx Corporation (NASDAQ:OPRX) Shares Do Insiders Own?

Jan 27
What Percentage Of OptimizeRx Corporation (NASDAQ:OPRX) Shares Do Insiders Own?

Financial Position Analysis

Short Term Liabilities: OPRX's short term assets ($54.3M) exceed its short term liabilities ($17.9M).

Long Term Liabilities: OPRX's short term assets ($54.3M) exceed its long term liabilities ($38.9M).


Debt to Equity History and Analysis

Debt Level: OPRX's net debt to equity ratio (17.7%) is considered satisfactory.

Reducing Debt: OPRX's debt to equity ratio has increased from 0% to 28.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OPRX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: OPRX has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 20.4% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.